Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
American Heart Journal|August 10, 2010
Cost and health outcome of primary percutaneous coronary intervention versus thrombolysis in acute ST-segment elevation myocardial infarction-Results of the Swedish Early Decision reperfusion Study (SWEDES) trialMikael Aasa, Martin Henriksson, Mikael Dellborg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 22, 2019
Health Care Costs of Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease Are Nearly Twice Those of Matched ControlsHannes Hagström, Patrik Nasr, Mattias Ekstedt, et al.
Scientific Reports|April 27, 2023
The cost-effectiveness of whole genome sequencing in neurodevelopmental disordersHannes Runheim, Maria Pettersson, Anna Hammarsjö, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 17, 2023
Laparoscopic distal pancreatectomy is more cost-effective than open resection: results from a Swedish randomized controlled trialKarin Johansen, Anna Lindhoff Larsson, Linda Lundgren, et al.
American Heart Journal|February 19, 2022
Clinical decision support for familial hypercholesterolemia (CDS-FH): Rationale and design of a cluster randomized trial in primary careOlof Persson Lindell, Lars O Karlsson, Staffan Nilsson, et al.
Scandinavian Journal of Urology and Nephrology|January 27, 2011
Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4)Swen-Olof Andersson, Ove Andrén, Johan Lyth, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 25, 2018
Toward Alignment in the Reporting of Economic Evaluations of Diagnostic Tests and Biomarkers: The AGREEDT ChecklistMichelle M A Kip, Maarten J IJzerman, Martin Henriksson, et al.
Chemmedchem|June 17, 2022
The First Structure of Human MTHFD2L and Its Implications for the Development of Isoform-Selective InhibitorsEmma R Scaletti, Robert Gustafsson Westergren, Yasmin Andersson, et al.
Bioorganic & Medicinal Chemistry Letters|June 30, 2007
Oxazolones as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 1Lori Sutin, Sören Andersson, Lars Bergquist, et al.
Cell Death and Differentiation|July 10, 2019
The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activityJaime A Espinoza, Asimina Zisi, Dimitris C Kanellis, et al.
Pageof 8